Page 142 - CW E-Magazine (18-6-2024)

Pharmaceuticals Hydrocarbons

MARKETING PRACTICES PETROLEUM PRODUCTS
Government seeks affi davits from pharma fi rms India’s refi ning capacity set to increase to 276-mtpa

on ethical practices by 2024

Executive heads of pharmaceutical It also bans the supply of free samples India’s crude oil production is (OALP). The eighth bidding round India’s push towards a gas-based
companies have been asked to submit to those who are not qualifi ed to pres- projected to hold steady at 29.4-mt under this policy has expanded India’s economy.
an undertaking to the government, cribe such a product. While pharma for 2023-24, even as petroleum pro- exploration acreage by an additional
citing compliance with provisions of companies have been following a code duct consumption is expected to reach 34,364.53-sq.km., bringing the total to The report highlights the govern-
Uniform Code for Pharmaceuticals for marketing practices since 2015, that 233.3-mt, up from 223.0-mt in the pre- 242,055-sq.km. This expansion is part ment’s focus on increasing the share of
Marketing Practices (UCPMP) 2024. was purely voluntary. The new code is vious year, refl ecting a steady growth in of a broader effort to accelerate explo- gas in the energy mix to 15% by 2030,
quasi-statutory. domestic demand. ration and production activities across with the introduction of the Compressed
The newly notifi ed UCPMP pro- the nation and reduce dependence on Bio-Gas (CBG) Blending Obligation in
hibits companies from organising The new code creates a mecha- According to the Ready Reckoner imported oil. the City Gas Distribution (CGD) sector.
workshops abroad for healthcare pro- nism of enforcement and oversight. report from the Petroleum Planning & This mandate will begin in FY 2025-26
fessionals or offering them hotel stay, The self-declaration must be fi lled Each of the pharma associations will Analysis Cell (PPAC) India’s refi ning ‘Natural gas sector seeing gradual with a 1% blending obligation, which
expensive cuisine or monetary grants and signed by the executive head of the have to create an ethics committee capacity is set to increase from 266.5- growth’ will escalate to 5% by 2028-29.
to control unethical practices in the company regarding compliance to the and a portal linked to the UCPMP mtpa in 2023-24 to 276.1-mtpa by the The natural gas sector is also see-
pharma industry. The government has UCPMP for FY25. The format says the portal. end of 2024-25. The expansion is in ing gradual growth, with production Additionally, the Reckoner discusses
asked pharma companies to submit an company undertakes to comply with line with India’s strategic goals to boost expected to increase from 33.664-bcm the integration of renewable energy
undertaking by June 30. The Depart- the provisions of the UCPMP 2024 The department will have a panel its processing capabilities to meet both (billion cubic meters) in 2022-23 to within the oil and gas sectors. A notable
ment of Pharmaceuticals (DoP) has and extend all required assistance to of auditors who will do a risk-based domestic and global oil demands. 35.717-bcm in 2023-24. Enhancements development is the National Biofuel
sent out a self-declaration form for authorities for the enforcement of this audit of such expenditure. If a breach in the natural gas infrastructure, includ- Coordination Committee’s setting of
FY25 under UCPMP to all pharma- code. According to the code notifi ed of the code is established, the com- In the realm of oil exploration, signi- ing an increase in pipeline connections Sustainable Aviation Fuel (SAF) blend-
ceutical associations for “strict by DoP in March, no gifts of personal mittee can propose to suspend or fi cant strides have been made through and a rise in the number of Compressed ing targets, with an initial target of 1%
compliance,” said a circular dated benefi t should be offered to healthcare expel the entity from the association, the Open Acreage Licensing Policy Natural Gas (CNG) stations, underline by 2027 for international fl ights.
May 28. professionals or their family members. as per the new code.

EXPANDED PORTFOLIO TECHNOLOGY SUPPORT
Lupin completes acquisition of Sanofi brands ONGC seeks global expertise to enhance production

Lupin has completed the acqui- The turnover of the brands in from Mumbai High
sition of two brands from Sanofi – these markets for the year ended
Aarane in Germany and Nalcrom in March 31, 2023, was about ONGC has said it is keen to engage High fi eld, which commenced produc- High fi eld, ONGC said it is keen to col-
Canada and the Netherlands – along $6.494-mn (Rs. 53-crore), international oil & gas companies to tion 48 years ago in 1976, is currently in laborate with a global ‘Technical Service
with the associated trademark rights. Lupin had then said. enhance production from its maturing its mature stage of production and ONGC Provider’. The service provider would
Mumbai High fi eld on the Arabian Sea. has implemented a number of schemes in be contracted for ten years, extendable
Mr. Fabrice Egros, Lupin’s Presi- Nalcrom (sodium cromo- this fi eld to improve production, it added. by another fi ve years. The identifi ed ser-
dent (corporate development) said, glicate – oral) belongs to the “ONGC is keen to engage an inter- vice provider would carry out a compre-
the acquisition would strengthen the anti-allergics segment and is nationally-proven ‘Technical Service Mumbai High is one of the prime hensive review of fi eld performance and
company’s global position in treating used to treat food allergies. Provider’ to enhance production from assets of ONGC and signifi cant upside identify improvements in Wells, Reser-
patients suffering from diverse Aarane (sodium cromogli- its maturing Mumbai High fi eld on is still to be unlocked here if ONGC voir including water injection, and facili-
respiratory diseases and conditions, cate/reproterol hydrochloride the Arabian Sea. The Service Provider applies best-in-class reservoir man- ties management, it added. The service
besides adding accretive assets in with French multinational Sanofi pressurised inhalation) is indicated in would be identifi ed through an inter- agement technologies and adopt glob- provider would suggest and help im-
gastro-intestinal care. to acquire a portfolio of established the symptomatic acute treatment of national competitive bidding (ICB), ally-best operational and management plement suitable technological inter-
products in Europe and Canada. The sudden asthma attacks (allergic forms already fl oated on June 1, 2024, with due practices. “All international oil & gas ventions to improve production. Inte-
Last December, the Mumbai-based purchase consideration was Euro 10-mn or those triggered by exertion, stress date for bid submission on September majors, having annual revenue above grated reservoir/FEED studies and the
fi rm had said that its Swiss subsi (Rs. 91-crore), besides sales mile- or infections) and targets the preven- 15, 2024,” the company said. $75-bn, are invited to participate in this development of a detailed work plan
diary, Lupin Atlantis Holdings SA, had stones up to Euro 8-mn (Rs. 72-crore), tion of exercise-induced asthma, a ICB,” the Maharatna company said. for fi eld development would also be
signed an Asset Purchase Agreement dependant on future sales, it had said. note from the company said. The giant multi-layered Mumbai As a custodian and operator of Mumbai within the scope of work.

142 Chemical Weekly June 18, 2024 Chemical Weekly June 18, 2024 143

Contents Index to Advertisers Index to Products Advertised